SAN BRUNO, California, September 19 /PRNewswire/ --

- InQuira to Demonstrate Integrated Self-Service Solution at Oracle OpenWorld(R)

LONDON, September 19 /PRNewswire/ --

Following recent market research, Innovations in Naturals 2008 has been developed to tackle the key technical challenges of moving towards the use of natural colours, flavours and preservatives, in both new and established products. This separately bookable 3 day event runs from 20 to 22 October 2008 at the New Connaught Rooms, London and is proving to be another hugely successful event from Food Ingredients Europe.

BRIGHTON, England, September 19 /PRNewswire/ -- Planon was recognized in the Leaders quadrant in Gartner's 2008 Magic Quadrant for Integrated Workplace Management Systems.(1) According to the report, "Leaders have strength in applications and platform technology, demonstrate a high level of quality in product reliability and service, have strong operational and organizational capabilities and financial stability, have global reach, and offer a strong vision of customer needs reflected in a robust development road map."

LONDON, September 19 /PRNewswire/ --

- Leveraging consumer trends to drive product innovation in the food, beverage and cosmetics markets

Health and Natural Ingredients alternate annual event has returned with a vibrant, innovative programme which aims to tackle to latest technical, legal and market industry challenges.

This event covers the hottest topics in the food and beverage industry, making this event a must attend date in the food industry calendar. The programme includes over 60 speakers with companies such as Unilever, Heinz, Hershey's, Ajinomoto, GlaxoSmithKline, L'Oreal, Kerry Ingredients and Cargill, presenting on cutting edge solutions to key industry challenges.

This conference features over 60 speakers

LONDON, September 19 /PRNewswire/ --

- Charity Welcomes Publication of Department of Health Tool

A new tool to help hospital doctors screen for Britain's most dangerous hospital killer is being rolled out across the country today and has the potential to save many of the 25,000 lives lost to the condition, but only if the measures are taken up by hospital managers, say Lifeblood: The Thrombosis Charity.

Hospital-acquired Deep Vein Thrombosis (DVT) is the commonest cause of hospital mortality, killing many more people in the UK than hospital -acquired infection. Yet, it is preventable with simple and effective risk assessment.

LEUVEN, Belgium, September 19 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease and cancer announces today its promotion to the Belgian Midcap index (Bel Mid Index or BELMID). After a quarterly review of Belgian indices by Euronext Brussels, ThromboGenics will enter the Bel Mid Index from October 1, 2008.